×

Register now for access to the Parexel Biotech Content Hub

First Name
Last Name
Company Name
Job Title
Country
Thank you!
Error - something went wrong!
   

Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

June 16, 2020

The past 20 years have seen a transformation in the field of precision medicine. Precision medicine has not only impacted drug development, but also drug discovery and disease diagnosis, allowing scientists to use molecular characteristics to define diseases and moving diagnosis away from clinical signs and symptoms. For biotech companies, this new landscape holds tremendous promise for innovation – for new drug targets, newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.

In this article, Angela Qu, MD, PhD, Vice President, and Arlene Hughes, PhD, Senior Director from Parexel's Translational Medicine Group offer insights about what biotechs should be thinking about from the start to utilize this approach to help bring innovation and new therapies to more patients.  

Previous Flipbook
Drug development innovations that work: Adaptive trial design - BioPharma Dive
Drug development innovations that work: Adaptive trial design - BioPharma Dive

Next Flipbook
The hidden value of early patient centricity: practical solutions for early phase trials
The hidden value of early patient centricity: practical solutions for early phase trials

Learn about five economical and efficient ways to make early phase trials both patient-centric and more eff...